NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship
- PMID: 16825909
- DOI: 10.1097/00042737-200608000-00016
NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship
Abstract
Background: Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract with variations in localization and behaviour. Mutations in the NOD2/CARD15 gene on chromosome 16q have been implicated in the pathogenesis of the disease and three main sequence variants, all single nucleotide polymorphisms (SNPs), have been identified in North American and European populations.
Aims and methods: As no data exist in the Croatian population, we consecutively collected a cohort of 136 CD patients and 91 healthy controls to determine the prevalence of NOD2/CARD15 mutations and their association with phenotypic expression of the disease. All patients and controls were genotyped for Arg702Trp (Hugot SNP8), Gly908Arg (Hugot SNP12), and Leu1007fsinsC (Hugot SNP13) and allele frequencies were compared between the Crohn's patients and controls. The correlation of NOD2/CARD15 genotypes with the phenotypic expression of Crohn's disease was further assessed by logistic regression analysis.
Results: NOD2/CARD15 variants were found in 38/136 CD patients (27.9%) compared to 10/91 (10.9%) healthy controls (P = 0.0022). Allele frequencies in patients with CD were 13.97%, 4.4% and 11.76%, respectively, for SNP8, 12 and 13, compared to 5.49%, 1.12% and 4.40% in controls (P = 0.041, P = 0.162, P = 0.055). Six CD patients carried double mutations and, remarkably, we identified two homozygous mutants amongst the healthy control group. Surgery over the course of the disease and a younger age at onset of the disease were significantly more frequent in patients who were carriers of NOD2/CARD15 mutations.
Conclusions: This report on NOD2/CARD15 mutations in Croatian patients with CD demonstrates that this gene is also implicated in susceptibility to CD in the Croatian population. Phenotypic association showed a younger age at diagnosis and a higher need for surgery in patients carrying NOD2/CARD15 mutations. However, the prevalence is somewhat lower compared to other reports, likely due to a more prominent colonic inflammation.
Similar articles
-
Detection of mutations in NOD2/CARD15 gene in Arab patients with Crohn's disease.Saudi J Gastroenterol. 2021 Jul-Aug;27(4):240-248. doi: 10.4103/sjg.sjg_582_20. Saudi J Gastroenterol. 2021. PMID: 34380868 Free PMC article.
-
NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.Bosn J Basic Med Sci. 2015 May 25;15(2):67-72. doi: 10.17305/bjbms.2015.348. Bosn J Basic Med Sci. 2015. PMID: 26042516 Free PMC article.
-
Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.Eur J Gastroenterol Hepatol. 2007 Mar;19(3):217-23. doi: 10.1097/01.meg.0000250590.84102.12. Eur J Gastroenterol Hepatol. 2007. PMID: 17301648
-
CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.Eur J Gastroenterol Hepatol. 2007 Jun;19(6):449-59. doi: 10.1097/01.meg.0000236887.44214.6a. Eur J Gastroenterol Hepatol. 2007. PMID: 17489054 Review.
-
Clinical applications of NOD2/CARD15 mutations in Crohn's disease.Acta Gastroenterol Latinoam. 2007 Mar;37(1):49-54. Acta Gastroenterol Latinoam. 2007. PMID: 17486745 Review.
Cited by
-
Detection of mutations in NOD2/CARD15 gene in Arab patients with Crohn's disease.Saudi J Gastroenterol. 2021 Jul-Aug;27(4):240-248. doi: 10.4103/sjg.sjg_582_20. Saudi J Gastroenterol. 2021. PMID: 34380868 Free PMC article.
-
A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease.Mycobact Dis. 2012 May 31;2:117. Mycobact Dis. 2012. PMID: 24494172 Free PMC article.
-
Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chronic human diarrheal diseases.Virulence. 2011 Mar-Apr;2(2):131-43. doi: 10.4161/viru.2.2.15647. Epub 2011 Mar 1. Virulence. 2011. PMID: 21460639 Free PMC article. Clinical Trial.
-
A 60-day probiotic protocol with Dietzia subsp. C79793-74 prevents development of Johne's disease parameters after in utero and/or neonatal MAP infection.Virulence. 2011 Jul-Aug;2(4):337-47. doi: 10.4161/viru.2.4.16137. Epub 2011 Jul 1. Virulence. 2011. PMID: 21701254 Free PMC article.
-
NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.Bosn J Basic Med Sci. 2015 May 25;15(2):67-72. doi: 10.17305/bjbms.2015.348. Bosn J Basic Med Sci. 2015. PMID: 26042516 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials